Evaluation of perospirone (SM-9018), a novel serotonin-2 and dopamine-2 receptor antagonist, and other antipsychotics in the conditioned fear stress-induced freezing behavior model in rats

Japanese Journal of Pharmacology

Volumn 72, Issue 2, 1996, Pages 119-126

  Ishida Tokuda, Kumiko ^a   Ohno, Yukihiro ^a   Sakamoto, Hideki ^a   Ishibashi, Tadashi ^a   Wakabayashi, Junko ^a   Tojima, Rie ^a   Morita, Tomoko ^a   Nakamura, Mitsutaka ^a  

^a DAINIPPON SUMITOMO PHARMA CO LTD   (Japan)

Author keywords

Antipsychotic; Conditioned fear stress; Freezing behavior; Perospirone; Schizophrenia

Indexed keywords

CHLORPROMAZINE; CLOSPIPRAMINE; CLOZAPINE; DESIPRAMINE; DIAZEPAM; DOPAMINE 2 RECEPTOR BLOCKING AGENT; HALOPERIDOL; IMIPRAMINE; KETANSERIN; NEUROLEPTIC AGENT; PEROSPIRONE; RISPERIDONE; RITANSERIN; SEROTONIN 2 ANTAGONIST; THIORIDAZINE; TIAPRIDE;

ANIMAL BEHAVIOR; ANIMAL EXPERIMENT; ANIMAL MODEL; ANXIETY; ARTICLE; CONTROLLED STUDY; DEPRESSION; DOSE RESPONSE; FEAR; FREEZING; MALE; MENTAL STRESS; MOOD; NONHUMAN; ORAL DRUG ADMINISTRATION; RAT; SHOCK; STRESS;

EID: 0029826027     PISSN: 00215198     EISSN: None     Source Type: Journal    
DOI: 10.1254/jjp.72.119     Document Type: Article

References (28)

1. Strauss JS, Carpenter WT Jr and Bartko JJ: The diagnosis and understanding of schizophrenia: III. Speculations on the processes that underlie schizophrenic symptoms and signs. Schizophr Bull 11, 61-76 (1974)
2. 2 receptor blocking agent. Curr Ther Res 40, 492-500 (1986)
3. Ceulemans DLS, Gelders YG, Hoppenbrouwers M-LJA, Reyntjens AJM and Janssen PAJ: Effect of serotonin antagonism in schizophrenia: a pilot study with setoperone. Psychopharmacology (Berlin) 85, 329-332 (1985)
4. Meltzer HY and Nash JF: Effects of antipsychotic drugs on serotonin receptors. Pharmacol Rev 43, 587-604 (1991)
5. Wagstaff AJ and Bryson HM: Clozapine: A review of its pharmacological properties and therapeutic use in patients with schizophrenia who are unresponsive to or intolerant of classical antipsychotic agents. CNS Drugs 4, 370-400 (1995)
6. 2 antagonistic actions. Jpn J Pharmacol 53, 321-329 (1990)
7. Maruoka Y, Ohno Y, Kato T, Hirose A, Tatsuno T and Nakamura M: Effects of SM-9018, a potential atypical neuroleptic, on the central monoaminergic system in rats. Jpn J Pharmacol 62, 419-422 (1993)
8. 3H]acetylcholine release from rat striatal slices. Gen Pharmacol (1996) (in press)
9. Ishibashi T, Ikeda K, Ishida K, Yasui J, Tojima R, Nakamura M and Ohno Y: Contrasting effects of SM-9018, a potential atypical antipsychotic, and haloperidol on c-fos mRNA expression in the rat striatum. Eur J Pharmacol 303, 247-251 (1996)
10. 2 receptor antagonist, using the mouse pole test. Pharmacol Biochem Behav 49, 19-23 (1994)
11. Ohno Y, Ishida K, Ishibashi T, Ikeda K, Kato T and Nakamura M: Effects of chronic treatments with SM-9018, a potential atypical neuroleptic, on behavioral dopaminergic and serotonergic sensitivity in rats. Gen Pharmacol 26, 489-494 (1995)
12. 2 antagonist, on dopamine and 5-HT receptors in rats. Prog Neuropsychopharmacol Biol Psychiatry 19, 1091-1101 (1995)
13. Murasaki M, Miura S and Kudo Y: Broad clinical spectrum of a new atypical neuroleptic, SM-9018 on positive and negative symptoms, and anxiety-depression in patients with schizophrenia. Abstract, Schizophrenia 1994: Exploring the Spectrum of Psychosis, Vancouver, pill (1994)
14. Chouinard G, Jones B, Remington G, Bloom D, Addington D, MacEwan GW, Labelle A, Beauclair L and Arnott W: A Canadian multicenter placebo-controlled study of fixed doses of risperidone and haloperidol in the treatment of chronic schizophrenic patients. J Clin Pharmacol 13, 25-40 (1993)
15. Gorka Z and Janus K: Effects of neuroleptics displaying antidepressant activity on behavior of rats in forced swimming test. Pharmacol Biochem Behav 23, 203-206 (1985)
16. Wiley JL, Compton AD and Porter JH: Effects of four antipsychotics on punished responding in rats. Pharmacol Biochem Behav 45, 263-267 (1993)
17. Fanselow MS: Conditional and unconditional components of post-shock freezing. Pavlov J Biol Sci 15, 177-182 (1980)
18. Inoue T, Koyama T and Yamashita I: From a standpoint of psychiatry: Effects of conditioned fear stress on monoaminergic systems in the rat brain. Jpn J Clin Pathol 40, 227-233 (1992) (Abstr in English)
19. Conti LH, Maciver CR, Ferkany JW and Abreu ME: Foot-shock-induced freezing behavior in rats as a model for assessing anxiolytics. Psychopharmacology (Berlin) 102, 492-497 (1990)
20. Fanselow MS and Helmstetter FJ: Conditional analgesia, defensive freezing, and benzodiazepines. Behav Neurosci 102, 233-243 (1988)
21. Hashimoto S, Inoue T and Koyama T: Serotonin reuptake in- hibitor reduce conditioned fear stress-induced freezing behavior in rats. Psychopharmacology (Berlin) 123, 182-186 (1996)
22. Beck CH and Fibiger HC: Chronic desipramine alters stress-induced behaviors and regional expression of the immediate early gene, c-fos. Pharmacol Biochem Behav 51, 331-338 (1995)
23. Inoue T, Koyama T and Yamashita I: Effects of conditioned fear stress on serotonin metabolism in the rat brain. Pharmacol Biochem Behav 44, 371-374 (1993)
24. Kawahara H, Yoshida M, Yokoo H, Nishi M and Tanaka M: Psychological stress increases serotonin release in the rat amygdala and prefrontal cortex assessed by in vivo microdialysis. Neurosci Lett 162, 81-84 (1993)
25. Gandolfi O, Barbaccia ML and Costa E: Comparison of iprindole, imipramine and mianserin action on brain serotonergic and beta adrenergic receptors. J Pharmacol Exp Ther 229, 782-786 (1984)
26. 2 receptor-mediated head-twitch behaviour following antidepressant treatment to mice. Br J Pharmacol 83, 235-242 (1984)
27. 2 receptor mRNA levels. Eur J Pharmacol 207, 169-172 (1991)
28. Noda Y, Yamada K, Furukawa H and Nabeshima T: Enhancement of immobility in a forced swimming test by subacute or repeated treatment with phencyclidine: a new model of schizophrenia. Br J Pharmacol 116, 2531-2537 (1995)